Compare Indonesian Paradise Property Tbk (INPP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesian Paradise Property Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Indonesian Paradise Property Tbk trades at Rp750 (market cap 8.39T, 14.9K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Indonesian Paradise Property Tbk is far larger — about 80.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| INPP | SCPI | |
|---|---|---|
Market Cap | 8.39T | 104.4B |
Volume | 14.9K | — |
Lot | 149 | — |
Turnover | 11.04M | — |
Average Price | 741.07 | — |
Value | 11.04M | — |
Indicative Equilibrium Price | 750 | — |
Indicative Equilibrium Volume | 23 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indonesian Paradise Property Tbk
PT. Indonesia Paradise Property Tbk (the Company) was established under the name of PT Penta Karsa Lubrindo based on Notarial Deed No. 96 dated June 14, 1996 of Buntario Tigris Darmawa, NG, S.H., CN., and was amended of Rachmat Santoso, S.H., Public Notary in Jakarta. The Company is an Indonesia-based company engaged in the property sector, hotel operation, general contractor and general trading. The Company's hotel is located in Bali, Indonesia.
Read more on INPP →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
